-
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
14 Jan 2026 21:23 GMT
… Frontline ovarian cancer treatment protocols involving bevacizumab, … (carboplatin/paclitaxel). Patients were randomized … drug action. About Gradalis, Inc.
Gradalis is a clinical-stage biotechnology … H). The FDA granted Regenerative Medicine Advanced Therapy …
-
Testicular Cancer: Diagnosis, Treatment, and Biomarker Advances
14 Jan 2026 04:53 GMT
… trials have compared the oncologic or toxicity benefits of these treatment … dose salvage chemotherapy (CDCT) with paclitaxel–ifosfamide–cisplatin (TIP) or … on medical research council trial TE18, European organisation for the research and treatment …
-
Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast Cancer
13 Jan 2026 15:26 GMT
… the ongoing TROPION-Breast02 trial (NCT05374512), which evaluated … + nab-paclitaxel was approved for first-line treatment of PD … the individual drug.
Table 1 The Clinical Trials of ADCs … facilitate the treatment of TNBC towards personalized medicine.
In the …
-
<![CDATA[Suvemcitug Plus Chemo Improves PFS and OS in Recurrent Ovarian Cancer]]>
15 Jan 2026 20:24 GMT
… with suvemcitug in this trial was statistically significant albeit … of OS in this trial that addressed subsequent antitumor … The median duration of treatment was longer in the … 39;s choice of chemotherapy (paclitaxel, topotecan, or PEGylated liposomal …
-
<![CDATA[Elraglusib Combo Yields Notable 24-Month Survival Benefit in Metastatic PDAC]]>
14 Jan 2026 23:36 GMT
… University Feinberg School of Medicine, in a news … standard gemcitabine and nab-paclitaxel chemotherapy may improve … research possible.”
The FDA granted orphan drug designation to elraglusib … response to inform personalized treatment strategies.
Actuate-1801 …
-
纳利瑞福斯对比吉西他滨治疗中国胰腺癌
16 Jan 2026 16:48 GMT
… plus nab-paclitaxel. Importantly, … precision medicine approaches … —spanning clinical trials, molecular biology … drug deliverynovel chemotherapy for canceroncological therapeutics advancementspancreatic adenocarcinoma treatmentphase II clinical trial …
-
Identification of circRNA/lncRNA-miRNA-Transcription Factor-mRNA Networks to Identify Potential Biomarkers in Response to Neoadjuvant Therapy for Breast Cancer
16 Jan 2026 14:58 GMT
… Affiliated Hospital of Inner Mongolia Medical University (approval number: YJS2024055), … treatment cycles, patients received docetaxel (100 mg/m2) or paclitaxel … Affiliated Hospital of Inner Mongolia Medical University (approval number: YJS2024055), …
-
<![CDATA[Pelareorep Plus Atezolizumab Drives Responses in Third-Line Squamous Cell Anal Carcinoma]]>
15 Jan 2026 04:39 GMT
… from the trial indicated that …
References
Oncolytics Biotech announces updated clinical … cancers exploring treatment combinations with … fda.gov/drugs/;resources-information-approved-drugs/fda-approves-retifanlimab-dlwr-carboplatin-and-paclitaxel …
-
<![CDATA[Dr Mouabbi on the Role of ctDNA Testing in Individualized Breast Cancer Care]]>
15 Jan 2026 04:39 GMT
… the Department of Breast Medical Oncology and the … trial platform as a foundational example of integrating ctDNA testing into treatment … decision-making. Across these trials, in … , the administration of paclitaxel alone resulted in the …
-
[JPM 2026] ABL Bio-origin tovecimig shows second-line potential in bile duct cancer
15 Jan 2026 04:05 GMT
… cancer.
U.S. biotech firm Compass Therapeutics presented … 3 COMPANION-002 (ABL001) trial. Schuetz also reaffirmed its … abnormal tumor vessel remodeling and treatment resistance.
“DLL4 helps … received either tovecimig plus paclitaxel or paclitaxel alone in a …
About
© 1995-2026